Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Friday . The company traded as low as GBX 102.20 ($1.31) and last traded at GBX 102.20 ($1.31), with a volume of 28546 shares. The stock had previously closed at GBX 113.50 ($1.45).
Arecor Therapeutics Trading Down 10.0 %
The company has a current ratio of 2.17, a quick ratio of 6.24 and a debt-to-equity ratio of 3.55. The stock has a 50 day simple moving average of GBX 134.57 and a 200-day simple moving average of GBX 145.78. The firm has a market cap of £31.30 million, a P/E ratio of -506.65 and a beta of -0.21.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Recommended Stories
- Five stocks we like better than Arecor Therapeutics
- How to Calculate Return on Investment (ROI)
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- Insider Buying Explained: What Investors Need to Know
- This Financial Stock’s Earnings Signal a Buying Opportunity
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
